1. Clinical practice guidelines for the management of adult diffuse gliomas.
- Author
-
Jiang, Tao, Nam, Do-Hyun, Ram, Zvi, Poon, Wai-sang, Wang, Jiguang, Boldbaatar, Damdindorj, Mao, Ying, Ma, Wenbin, Mao, Qing, You, Yongping, Jiang, Chuanlu, Yang, Xuejun, Kang, Chunsheng, Qiu, Xiaoguang, Li, Wenbin, Li, Shaowu, Chen, Ling, Li, Xuejun, Liu, Zhixiong, and Wang, Weimin
- Subjects
- *
GUIDELINES , *GLIOMAS , *MOLECULAR diagnosis , *BRAIN cancer , *CANCER treatment , *GLIOMA treatment , *BRAIN tumor treatment , *THERAPEUTIC use of antineoplastic agents , *BRAIN , *COMPUTERS in medicine , *GENETIC mutation , *NEUROLOGY , *NEUROSURGERY , *MAGNETIC resonance imaging , *BRAIN tumors , *COMPUTED tomography , *RADIOTHERAPY , *TUMOR grading , *ONCOLOGY , *MEDICAL societies ,BRAIN tumor diagnosis - Abstract
To follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro-Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updated the clinical practice guideline. It provides recommendations for diagnostic and management decisions, and for limiting unnecessary treatments and cost. The recommendations focus on molecular and pathological diagnostics, and the main treatment modalities of surgery, radiotherapy, and chemotherapy. In this guideline, we also integrated the results of some clinical trials of immune therapies and target therapies, which we think are ongoing future directions. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China and other countries. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF